Literature DB >> 8573619

Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".

C Y Chen1, Y N Chang, P Ryan, M Linscott, G J McGarrity, Y L Chiang.   

Abstract

Transfer of the herpes simplex virus type-1 thymidine kinase (HSV-tk) gene into tumor cells followed by ganciclovir (GCV) administration, will provide selective tumor cell killing. We studied the effect of herpes simplex virus thymidine kinase (HSV-tk) expression level on the HSV-tk/GCV-mediated "bystander effect." Clones of HSV-tk-transduced rat glioma cells (9L) were isolated that stably expressed with different levels of HSV-tk. All clones studied had similar sensitivity to ganciclovir with IC50 values ranging from 0.45 to 1.3 microM. Within certain enzyme level thresholds, in vitro evaluation of the bystander effect has shown that clones with higher level of HSV-tk expression exhibited a better bystander effect. Interestingly, the bystander effect was observed between different cell types. Both the transduction efficiency and bystander effect are essential factors for the success of the antitumor effect by the HSV-tk/prodrug GCV suicide gene system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8573619     DOI: 10.1089/hum.1995.6.11-1467

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  20 in total

1.  Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.

Authors:  Michael D Prados; Michael McDermott; Susan M Chang; Charles B Wilson; James Fick; Kenneth W Culver; John Van Gilder; G Evren Keles; Alex Spence; Mitchel Berger
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

Review 2.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

Review 3.  Prognostic utility of gene therapy with herpes simplex virus thymidine kinase for patients with high-grade malignant gliomas: a systematic review and meta analysis.

Authors:  Fei Zhao; Jinhui Tian; Lifeng An; Kehu Yang
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

4.  Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system.

Authors:  J J Hwang; Z Scuric; W F Anderson
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.

Authors:  Qiao Meng; Stacy R Hagemeier; Joyce D Fingeroth; Edward Gershburg; Joseph S Pagano; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

Review 6.  The art of gene therapy for glioma: a review of the challenging road to the bedside.

Authors:  Alex Tobias; Atique Ahmed; Kyung-Sub Moon; Maciej S Lesniak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-19       Impact factor: 10.154

Review 7.  Gene therapy and targeted toxins for glioma.

Authors:  Maria G Castro; Marianela Candolfi; Kurt Kroeger; Gwendalyn D King; James F Curtin; Kader Yagiz; Yohei Mineharu; Hikmat Assi; Mia Wibowo; A K M Ghulam Muhammad; David Foulad; Mariana Puntel; Pedro R Lowenstein
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

8.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Level of endothelial cell apoptosis required for a significant decrease in microvessel density.

Authors:  Zhihong Dong; Benjamin D Zeitlin; Wenying Song; Qinghua Sun; Elisabeta Karl; David M Spencer; Harsh V Jain; Trachette Jackson; Gabriel Núñez; Jacques E Nör
Journal:  Exp Cell Res       Date:  2007-07-28       Impact factor: 3.905

Review 10.  Adeno-associated virus (AAV) vectors in cancer gene therapy.

Authors:  Jorge L Santiago-Ortiz; David V Schaffer
Journal:  J Control Release       Date:  2016-01-12       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.